A thorough stability assessment of your biologics candidates during early development is crucial to identify and prevent potential downstream issues like aggregation or loss of function from unfolding. High-quality information on your candidates’ biophysical properties facilitates the decision-making process for candidate selection.
Dynamic Light Scattering (DLS) is a powerful method that provides information about the purity and aggregation state of your biologics preps, and adds deeper insight into the stability of your candidates.
The additional stability parameters granted by DLS are easily obtained alongside other stability profiling methods, without additional time or material requirements. Adding DLS information to your stability assessments reveals liabilities missed by other technologies and narrows down your final candidate earlier in your development workflow.
Read this eBook to learn how DLS works, and how it helps you improve the selection process for your candidates.
Want to see more
biologics content?
See more related content
How early discovery and development teams use Dynamic Light Scattering to de-risk downstream biologics development
As a discovery or early development scientist, you’re tasked with identifying the most promising biologics candidates. Your hard work during early development enables straightforward and efficient...
Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and where they’ll happen, who’ll be there, and the main focus.
8 biologics conferences you won’t want to miss in 2023
When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeutics approvals, and big pharma news, but nothing matches the biologics conference experience.
18:48Join Thomas Schubert, CEO of 2bind, as he walks through thermal and colloidal stability experiments done on the Prometheus Panta to determine the optimal formulation buffer for a vaccine candidate.
5 experiments in biologics that can be improved with dynamic light scattering
Biologics, which are drugs and treatments derived from natural products, undergo a long development process before they reach the clinic. When you invest a lot of time and money in the process to...
How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics
28:21Join Dr. Brittney Mills as she explains what criteria AbbVie’s preformulation department screens for in their antibody candidates.
5 formulation changes you can evaluate with Dynamic Light Scattering to increase your biologics candidates’ success
Biologics researchers are deeply concerned with formulation. Formulation typically refers to the final development of a deliverable, biologically derived molecule (such as a protein, peptide,...
Biologics developability: learn how Merck uses Prometheus Panta to create developability profiles for their mAbs
2:34Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal buffer for a vaccine antigen target.
4:51Four integrated technologies for Biologics developability assessment
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics
Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry
1:31How Janssen optimizes the stability of a therapeutic mAb
Discover how Janssen improved the stability of a promising prostate cancer targeting mAb. You’ll learn why it is important to optimize stability measurements of a therapeutic mAb.
22:36Hear how Dr. Sathya Venkataramani from Janssen Biotherapeutics maximized protein stability using the Prometheus in a real life case study about the design and characterization of antibody-based drugs.
34:16Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and see a few examples of how DLS gives you deeper insights.
Biologics formulation: learn how Boehringer Ingelheim uses Prometheus to find optimal buffer conditions for their mAbs